Best Acne Treatment is Acnaut Active Lotion!
The Acnaut active lotion is designed for special care for oily and blemish-prone skin with breakouts on the face, back, and neck.
Also for the prevention of ingrown hairs!
Its unique formula effectively treats oiliness and prevents the appearance of blocked pores and breakouts on the skin.
It is suitable for daily use and does not affect the photosensitivity of the skin.
Soothes the irritation after shaving and prevents ingrown hairs after epilation.
The first results with proper use of Acnaut Active Lotion are visible within 7 days.
Suitable for:
Oily skin with numerous breakouts on the face and body
Enlarged and blocked pores
Ingrown hairs after epilation
Effect:
The lotion effectively treats breakouts
Prevents the new breakouts and blocked pores
Removes oiliness
Soothes the irritation after shaving
Reduces ingrown hairs after epilation
Does not cause photosensitivity
How to use:
Twice a day apply the lotion with a cotton pad on cleansed skin all over the face, avoiding eye contour area. In case of single breakouts apply the lotion 2-3 times a day only on these affected spots.
Moisturizing cream, such as Acnaut Hyrdo Active Cream, and/or makeup can be applied at least 10-15 minutes after the lotion.
To prevent ingrown hairs — apply the lotion right after the epilation and repeat after a few hours. Follow this routine in next couple of days.
Important:
- After using the active lotion wash your hands with water!
Acnaut did it again!
Nothing but praises to #Acnaut Active Lotion by #biotrade cosmeceuticals for once again winning #RSVP Magazine Beauty Award in “Best Acne Treatment” category! It’s a recognition confirming the outstanding performance of our top seller product which over 25 years now changes customers’ lives and makes them look at the mirror with regained confidence. Thank you, RSVP, for being the voice of truth and care!
https://biotrade.global/rsvp-beauty-awards/
Read how Acnaut has changed lives here ⇓
https://biotrade.au/our-story/
Reviews
There are no reviews yet.